425 related articles for article (PubMed ID: 7486872)
21. ApoE polymorphism in Polish patients with Alzheimer's disease.
Lalowski MM; Czyzewski K; Pfeffer A; Barcikowska M; Kwieciński H
Acta Neurobiol Exp (Wars); 1998; 58(1):65-8. PubMed ID: 9583189
[TBL] [Abstract][Full Text] [Related]
22. APOE genotype: no influence on galantamine treatment efficacy nor on rate of decline in Alzheimer's disease.
Aerssens J; Raeymaekers P; Lilienfeld S; Geerts H; Konings F; Parys W
Dement Geriatr Cogn Disord; 2001; 12(2):69-77. PubMed ID: 11173877
[TBL] [Abstract][Full Text] [Related]
23. [Apolipoprotein E 4 gene is a risk factor for Alzheimer's disease].
Peng D; Xu X; Feng Y
Zhonghua Nei Ke Za Zhi; 2001 Oct; 40(10):688-90. PubMed ID: 11769724
[TBL] [Abstract][Full Text] [Related]
24. Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease.
Gomez-Isla T; West HL; Rebeck GW; Harr SD; Growdon JH; Locascio JJ; Perls TT; Lipsitz LA; Hyman BT
Ann Neurol; 1996 Jan; 39(1):62-70. PubMed ID: 8572669
[TBL] [Abstract][Full Text] [Related]
25. A twin study of late-onset depression and apolipoprotein E epsilon 4 as risk factors for Alzheimer's disease.
Steffens DC; Plassman BL; Helms MJ; Welsh-Bohmer KA; Saunders AM; Breitner JC
Biol Psychiatry; 1997 Apr; 41(8):851-6. PubMed ID: 9099411
[TBL] [Abstract][Full Text] [Related]
26. Distribution of apolipoprotein E4 isoform in Alzheimer's disease in Poland.
Bratosiewicz-Zapart J; Kłoszewska I; Sobów T; Liberski PP
Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):221-2. PubMed ID: 9597090
[TBL] [Abstract][Full Text] [Related]
27. Apolipoprotein E (APOE) allele frequencies in late-onset sporadic Alzheimer's disease (AD), mixed dementia and vascular dementia: lack of association of epsilon 4 allele with AD in Italian octogenarian patients.
Scacchi R; De Bernardini L; Mantuano E; Donini LM; Vilardo T; Corbo RM
Neurosci Lett; 1995 Dec; 201(3):231-4. PubMed ID: 8786847
[TBL] [Abstract][Full Text] [Related]
28. Apolipoprotein E genotypes in sporadic early and late-onset Alzheimer's disease.
Kowalska A; Florczak J; Pruchnik-Wolińska D; Kraszewski A; Wender M
Arch Immunol Ther Exp (Warsz); 1998; 46(3):177-81. PubMed ID: 9704150
[TBL] [Abstract][Full Text] [Related]
29. Reduced apolipoprotein epsilon 4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals.
Rebeck GW; Perls TT; West HL; Sodhi P; Lipsitz LA; Hyman BT
Neurology; 1994 Aug; 44(8):1513-6. PubMed ID: 8058160
[TBL] [Abstract][Full Text] [Related]
30. Risk and protective effects of the APOE gene towards Alzheimer's disease in the Kungsholmen project: variation by age and sex.
Qiu C; Kivipelto M; Agüero-Torres H; Winblad B; Fratiglioni L
J Neurol Neurosurg Psychiatry; 2004 Jun; 75(6):828-33. PubMed ID: 15145993
[TBL] [Abstract][Full Text] [Related]
31. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
[TBL] [Abstract][Full Text] [Related]
32. APOE epsilon 3/ epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis.
Fukumoto H; Ingelsson M; Gårevik N; Wahlund LO; Nukina N; Yaguchi Y; Shibata M; Hyman BT; Rebeck GW; Irizarry MC
Exp Neurol; 2003 Sep; 183(1):249-53. PubMed ID: 12957508
[TBL] [Abstract][Full Text] [Related]
33. [An association analysis of apolipoprotein E genotypes with Alzheimer's disease in Chinese population].
Wu YN; Zhang JW; Zhang ZX; Qu QM; Chen D
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Oct; 23(5):450-4. PubMed ID: 12905860
[TBL] [Abstract][Full Text] [Related]
34. [Apolipoprotein E genotype as a risk factor in Japanese patients with early-onset and late-onset Alzheimer's disease].
Shimada K; Yasuda M; Maeda K
Seishin Shinkeigaku Zasshi; 1997; 99(8):575-87. PubMed ID: 9369084
[TBL] [Abstract][Full Text] [Related]
35. Interaction of the H63D mutation in the hemochromatosis gene with the apolipoprotein E epsilon 4 allele modulates age at onset of Alzheimer's disease.
Combarros O; García-Román M; Fontalba A; Fernández-Luna JL; Llorca J; Infante J; Berciano J
Dement Geriatr Cogn Disord; 2003; 15(3):151-4. PubMed ID: 12584430
[TBL] [Abstract][Full Text] [Related]
36. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease.
Corder EH; Saunders AM; Risch NJ; Strittmatter WJ; Schmechel DE; Gaskell PC; Rimmler JB; Locke PA; Conneally PM; Schmader KE
Nat Genet; 1994 Jun; 7(2):180-4. PubMed ID: 7920638
[TBL] [Abstract][Full Text] [Related]
37. Polygenic determinants of Alzheimer's disease: modulation of the risk by alpha-1-antichymotrypsin.
DeKosky ST; Aston CE; Kamboh MI
Ann N Y Acad Sci; 1996 Dec; 802():27-34. PubMed ID: 8993481
[TBL] [Abstract][Full Text] [Related]
38. No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease.
Murphy GM; Taylor J; Kraemer HC; Yesavage J; Tinklenberg JR
Am J Psychiatry; 1997 May; 154(5):603-8. PubMed ID: 9137113
[TBL] [Abstract][Full Text] [Related]
39. Apolipoprotein E polymorphism in elderly east Africans.
Sayi JG; Patel NB; Premkumar DR; Adem A; Winblad B; Matuja WB; Mtui EP; Gatere S; Friedland RP; Koss E; Kalaria RN
East Afr Med J; 1997 Oct; 74(10):668-70. PubMed ID: 9529753
[TBL] [Abstract][Full Text] [Related]
40. Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease.
Dal Forno G; Rasmusson DX; Brandt J; Carson KA; Brookmeyer R; Troncoso J; Kawas CH
Arch Neurol; 1996 Apr; 53(4):345-50. PubMed ID: 8929157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
